These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 2447718)
21. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma. Comin CE; Novelli L; Boddi V; Paglierani M; Dini S Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372 [TBL] [Abstract][Full Text] [Related]
22. Wilms tumor 1/cytokeratin dual-color immunostaining reveals distinctive staining patterns in metastatic melanoma, metastatic carcinoma, and mesothelial cells in pleural fluids: an effective first-line test for the workup of malignant effusions. Conner JR; Cibas ES; Hornick JL; Qian X Cancer Cytopathol; 2014 Aug; 122(8):586-95. PubMed ID: 25044880 [TBL] [Abstract][Full Text] [Related]
23. Reactivity of six antibodies in effusions of mesothelioma, adenocarcinoma and mesotheliosis: stepwise logistic regression analysis. Dejmek A; Hjerpe A Cytopathology; 2000 Feb; 11(1):8-17. PubMed ID: 10714371 [TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical properties of malignant mesothelioma cells in histologic and cytologic specimens. Motoyama T; Watanabe T; Okazaki E; Tanaka N; Watanabe H Acta Cytol; 1995; 39(2):164-70. PubMed ID: 7534025 [TBL] [Abstract][Full Text] [Related]
25. Keratin in human lung tumors. Patterns of localization of different-molecular-weight keratin proteins. Said JW; Nash G; Banks-Schlegel S; Sassoon AF; Murakami S; Shintaku IP Am J Pathol; 1983 Oct; 113(1):27-32. PubMed ID: 6194690 [TBL] [Abstract][Full Text] [Related]
26. Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of Leu M1 antigen. Sheibani K; Battifora H; Burke JS Am J Pathol; 1986 May; 123(2):212-9. PubMed ID: 2422942 [TBL] [Abstract][Full Text] [Related]
27. Distinction between carcinoma cells and mesothelial cells in serous effusions. Usefulness of immunohistochemistry. Tickman RJ; Cohen C; Varma VA; Fekete PS; DeRose PB Acta Cytol; 1990; 34(4):491-6. PubMed ID: 2197840 [TBL] [Abstract][Full Text] [Related]
28. Carcinoembryonic antigen and milk-fat globule protein staining of malignant mesothelioma and adenocarcinoma of the lung. Tron V; Wright JL; Churg A Arch Pathol Lab Med; 1987 Mar; 111(3):291-3. PubMed ID: 2435259 [TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical localization of prekeratin filaments in benign and malignant cells in effusions. Comparison with intermediate filament distribution by electron microscopy. Kahn HJ; Hanna W; Yeger H; Baumal R Am J Pathol; 1982 Nov; 109(2):206-14. PubMed ID: 6182803 [TBL] [Abstract][Full Text] [Related]
30. Immunocytochemistry in the differential diagnosis of effusions: use of logistic regression to select a panel of antibodies to distinguish adenocarcinomas from mesothelial proliferations. Frisman DM; McCarthy WF; Schleiff P; Buckner SB; Nocito JD; O'Leary TJ Mod Pathol; 1993 Mar; 6(2):179-84. PubMed ID: 8483888 [TBL] [Abstract][Full Text] [Related]
31. The distinction of adenocarcinoma from malignant mesothelioma in cell blocks of effusions: the role of routine mucin histochemistry and immunohistochemical assessment of carcinoembryonic antigen, keratin proteins, epithelial membrane antigen, and milk fat globule-derived antigen. Cibas ES; Corson JM; Pinkus GS Hum Pathol; 1987 Jan; 18(1):67-74. PubMed ID: 2434407 [TBL] [Abstract][Full Text] [Related]
32. Distinction between cells in serous effusions using a panel of antibodies. Lauritzen AF Virchows Arch A Pathol Anat Histopathol; 1987; 411(3):299-304. PubMed ID: 2441518 [TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical evaluation of seven monoclonal antibodies for differentiation of pleural mesothelioma from lung adenocarcinoma. Wirth PR; Legier J; Wright GL Cancer; 1991 Feb; 67(3):655-62. PubMed ID: 1702354 [TBL] [Abstract][Full Text] [Related]
34. [Immunohistochemistry of mesotheliomas. Technique and current diagnostic contribution of immunohistochemical markers. General review]. Galateau-Salle F Arch Anat Cytol Pathol; 1993; 41(5-6):212-22. PubMed ID: 8135582 [TBL] [Abstract][Full Text] [Related]
35. Differential diagnosis between mesothelioma and adenocarcinoma: a multimodal approach based on ultrastructure and immunocytochemistry. Bedrossian CW; Bonsib S; Moran C Semin Diagn Pathol; 1992 May; 9(2):124-40. PubMed ID: 1609155 [TBL] [Abstract][Full Text] [Related]
36. Differential diagnosis between mesotheliomas and metastatic adenocarcinomas using monoclonal antibodies against gastrointestinal carcinoma antigen and stage-specific embryonic antigen. Ernst CS; Atkinson B; Chianese D; Peters J; Perry M; Herlyn M; Koprowski H Appl Pathol; 1986; 4(3):115-24. PubMed ID: 2885017 [TBL] [Abstract][Full Text] [Related]
37. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma. Berezowski K; Stastny JF; Kornstein MJ Mod Pathol; 1996 Apr; 9(4):426-9. PubMed ID: 8729984 [TBL] [Abstract][Full Text] [Related]
38. Hepatocellular carcinoma with mesothelioma-like dissemination. Otsuki Y; Shimizu S; Hosoda Y; Nagasawa M; Sato Y; Kobayashi H Pathol Int; 2005 Nov; 55(11):738-44. PubMed ID: 16271087 [TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma. Holden J; Churg A Am J Surg Pathol; 1984 Apr; 8(4):277-9. PubMed ID: 6201076 [TBL] [Abstract][Full Text] [Related]
40. The diagnostic value of thrombomodulin immunolocalization in serous effusions. Ascoli V; Scalzo CC; Taccogna S; Nardi F Arch Pathol Lab Med; 1995 Dec; 119(12):1136-40. PubMed ID: 7503662 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]